肥厚性およびケロイド瘢痕治療の世界市場レポート 2024年

肥厚性およびケロイド瘢痕治療治療の市場規模は近年急速に拡大しています。2023年の69億1,000万米ドルから2024年には76億7,000万米ドルへとCAGR11.0％で拡大します。過去期間に見られた拡大は、肥厚性瘢痕やケロイド瘢痕の発生率の増加、瘢痕評価技術の進歩、局所治療、外科的・侵襲的処置の普及、瘢痕改善に対する患者の需要の高まりなどの要因によるものです。

肥厚性およびケロイド瘢痕治療治療市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR9.8％で111億4,000万米ドルに成長します。予測期間中に予想される成長は、低侵襲的介入の出現、瘢痕修正技術の進歩、併用療法への関心の高まり、認知度の向上と早期介入、世界の美容動向などに起因すると考えられます。予測期間中に予想される主な動向としては、瘢痕治療のための注射療法の出現、相乗効果を狙った併用療法の利用、瘢痕管理に対する患者中心のアプローチ、瘢痕評価技術の開発、肥厚性およびケロイド瘢痕治療治療分野におけるフォローアップや診察のための遠隔医療の利用などが挙げられます。

肥厚性およびケロイド瘢痕治療治療市場は、交通事故と熱傷症例の増加により成長が見込まれています。少なくとも1台の車両と個人が関与する交通事故は、結果として生じる傷跡に対処するための注意と効果的な治療が必要です。肥厚性およびケロイド瘢痕治療治療は、瘢痕の高さや硬さを下げるのに重要な役割を果たし、市場の拡大に貢献しています。例えば、2022年8月の米国道路交通安全局（National Highway Traffic Safety Administration）の統計によると、2022年1～3月の自動車交通事故死亡者数は2021年の同時期と比較して7%近く増加しており、このようなケースにおける瘢痕治療の必要性が浮き彫りになっています。

肥厚性およびケロイド瘢痕治療治療市場もまた、美容施術の普及に伴って拡大が見込まれています。非侵襲的または低侵襲的な美容治療によって外見を向上させることを目的とする美容整形では、審美的に結果を改善するために瘢痕治療を取り入れることが多いです。肥厚性およびケロイド瘢痕治療治療市場はこの動向の恩恵を受け、より滑らかで美しい外見に貢献しています。The Aesthetic Societyは、2021年の米国の形成外科手術件数が54%増と大幅に増加すると報告しており、審美的介入に対する需要が高まっていることを示しています。

2023年の肥厚性およびケロイド瘢痕治療治療市場では北米が最大地域でした。アジア太平洋は、肥厚性およびケロイド瘢痕治療治療の世界市場レポートにおいて、予測期間中に最も急成長する地域となる見込みです。肥厚性およびケロイド瘢痕治療治療市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の肥厚性およびケロイド瘢痕治療市場、治療別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 凍結療法
• 外科的切除
• 圧迫包帯
• 病変内5-フルオロウラシル
• 表面X線
• 病変内コルチコステロイド注射
• その他
• 世界の肥厚性およびケロイド瘢痕治療市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 外用製品
• レーザー製品
• 注射
• その他
• 世界の肥厚性およびケロイド瘢痕治療市場、瘢痕別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 肥厚性瘢痕
• ケロイド瘢痕
• 世界の肥厚性およびケロイド瘢痕治療市場、最終用途別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• クリニック
• その他

第7章 地域および国の分析

• 世界の肥厚性およびケロイド瘢痕治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の肥厚性およびケロイド瘢痕治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 肥厚性およびケロイド瘢痕治療市場の競合情勢
• 肥厚性およびケロイド瘢痕治療市場の企業プロファイル
  • Smith &Nephew plc
  • Merz Pharmaceutical LLC
  • Lumenis Ltd.
  • Enaltus LLC
  • Sonoma Pharmaceuticals Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Hypertrophic And Keloid Scar Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hypertrophic and keloid scar treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hypertrophic and keloid scar treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The hypertrophic and keloid scar treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Treatment: Cryotherapy; Surgical Excision; Pressure Dressings; Intralesional 5-Fluorouracil; Superficial X-Ray; Intralesional Corticosteroid Injection; Other Treatments
• 2) By Products: Topical Products; Laser Products; Injectables; Other Products
• 3) By Scar: Hypertrophic Scars; Keloid Scars
• 4) By End-Use: Hospitals; Clinics; Other End-Users
• Companies Mentioned: Smith & Nephew plc; Merz Pharmaceutical LLC; Lumenis Ltd.; Enaltus LLC; Sonoma Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Hypertrophic and keloid scar treatment involves addressing scars that either remain within the boundaries of the original wound (hypertrophic) or extend beyond those boundaries and do not regress (keloids). Hypertrophic scars are contained within the area of the initial injury, while keloids spread outside the boundaries of the initial damage.

The main treatments for hypertrophic and keloid scars include cryotherapy, surgical excision, pressure dressings, intralesional 5-fluorouracil, superficial X-ray, intralesional corticosteroid injection, and others. Cryotherapy is a medical procedure that uses extremely cold liquid or a cryoprobe to freeze and destroy abnormal tissue. It is employed to destroy the core of keloid scars while preserving surface-level cells and tissues. Various products, including topical products, laser products, injectables, and others, are used during treatment. The end-users of hypertrophic and keloid scar treatment include hospitals, clinics, and other healthcare facilities.

The hypertrophic and keloid scar treatment market research report is one of a series of new reports from The Business Research Company that provides hypertrophic and keloid scar treatment market statistics, including hypertrophic and keloid scar treatment industry global market size, regional shares, competitors with a hypertrophic and keloid scar treatment market share, detailed hypertrophic and keloid scar treatment market segments, market trends and opportunities, and any further data you may need to thrive in the hypertrophic and keloid scar treatment industry. This hypertrophic and keloid scar treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hypertrophic and keloid scar treatment market size has grown rapidly in recent years. It will grow from $6.91 billion in 2023 to $7.67 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The expansion observed during the historical period can be attributed to factors such as the increased incidence of hypertrophic and keloid scars, advancements in scar assessment techniques, widespread adoption of topical treatments, surgical and invasive procedures, and growing patient demand for scar improvement.

The hypertrophic and keloid scar treatment market size is expected to see strong growth in the next few years. It will grow to $11.14 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The anticipated growth in the forecast period can be attributed to emerging minimally invasive interventions, advancements in scar revision techniques, a growing interest in combination therapies, increasing awareness and early intervention, and global aesthetic trends. Major trends expected in the forecast period include the emergence of injectable therapies for scar treatment, the use of combination therapies for synergistic effects, patient-centric approaches to scar management, the development of scar assessment technologies, and the utilization of telemedicine for follow-up and consultations in the field of hypertrophic and keloid scar treatment.

The hypertrophic and keloid scar treatment market is anticipated to witness growth due to an increase in the number of road accidents and burn cases. Road accidents involving at least one vehicle and individuals necessitate attention and effective treatment to address resulting scars. Hypertrophic and keloid scar treatments play a crucial role in lowering the height and tightness of scars, contributing to the market's expansion. For instance, statistics from the National Highway Traffic Safety Administration in August 2022 revealed a nearly 7% increase in motor vehicle traffic accident fatalities during the first three months of 2022 compared to the same period in 2021, highlighting the need for scar treatments in such cases.

The market for hypertrophic and keloid scar treatment is also expected to grow with the increasing prevalence of aesthetic procedures. Aesthetic procedures, which aim to enhance appearance through non-invasive or minimally invasive cosmetic treatments, often incorporate scar treatment to improve the outcome aesthetically. The hypertrophic and keloid scar treatment market benefits from this trend, contributing to a smoother and more pleasing appearance. The Aesthetic Society reported a significant 54% rise in US plastic surgical procedures in 2021, indicating a growing demand for aesthetic interventions.

Leading companies in the hypertrophic and keloid scar treatment market are strategically focusing on the development of clinically proven solutions, particularly those based on silicone, such as medical-grade silicone strips. These therapeutic products made from high-quality silicone are formulated to promote scar healing and reduction, offering an effective solution for various scar types. An example is Scar Erase, a UK-based company, which launched clinically tested silicone strips designed for scar healing and reduction, catering to hypertrophic, keloid, post-surgery, and stretch mark scars.

Major players in the market are also investing in advanced dermatological lines that leverage innovative technologies such as Microcyn technology. This technology accelerates wound healing, combats infections, and alleviates symptoms, providing clinically proven solutions. Sonoma Pharmaceuticals, a US-based pharmaceutical company, introduced a line of office dispensed products, including Regenacyn Plus, which is clinically proven to enhance the appearance of keloid and hypertrophic scars, offering relief from itch and pain while reducing infection risk.

In July 2022, Sinclair Pharma, a UK-based aesthetics company, completed the acquisition of Viora Ltd. The financial details of the acquisition remain undisclosed. This strategic move is expected to grant Sinclair access to Viora's portfolio of non-invasive and minimally invasive aesthetic devices. Additionally, the acquisition is anticipated to facilitate Sinclair's entry into the US market on a commercial scale. Viora Ltd., based in the US, specializes in providing medical aesthetic devices and solutions, including offerings related to scar and stretch mark revision, acne clearance, and various other aesthetic treatments.

Major companies operating in the hypertrophic and keloid scar treatment market report are Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Mylan N.V., Stratpharma AG, Revitol Corporation Inc., Quantum Health, Scarfade, Biodermis, Renovo Group plc, Mederma, Silagen

North America was the largest region in the hypertrophic and keloid scar treatment market in 2023. Asia-pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hypertrophic and keloid scar treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hypertrophic and keloid scar treatment market consist of revenues earned by entities by providing occlusive dressings, compression therapy, intralesional corticosteroid injections, cryosurgery, excision, radiation therapy, laser therapy, interferon (IFN) therapy, doxorubicin, bleomycin, and verapamil. The market value includes the value of related goods sold by the service provider or included within the service offering. The hypertrophic and keloid scar treatment market also includes sales of skin camouflage, silicon gels, and skin needling. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Hypertrophic And Keloid Scar Market Characteristics

3. Hypertrophic And Keloid Scar Market Trends And Strategies

4. Hypertrophic And Keloid Scar Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Hypertrophic And Keloid Scar Market Size and Growth

• 5.1. Global Hypertrophic And Keloid Scar Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Hypertrophic And Keloid Scar Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Hypertrophic And Keloid Scar Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hypertrophic And Keloid Scar Market Segmentation

• 6.1. Global Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Cryotherapy
• Surgical Excision
• Pressure Dressings
• Intralesional 5-Fluorouracil
• Superficial X-Ray
• Intralesional Corticosteroid Injection
• Other Treatments
• 6.2. Global Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Topical Products
• Laser Products
• Injectables
• Other Products
• 6.3. Global Hypertrophic And Keloid Scar Market, Segmentation By Scar, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hypertrophic Scars
• Keloid Scars
• 6.4. Global Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Other End-Users

7. Hypertrophic And Keloid Scar Market Regional And Country Analysis

• 7.1. Global Hypertrophic And Keloid Scar Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Hypertrophic And Keloid Scar Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hypertrophic And Keloid Scar Market

• 8.1. Asia-Pacific Hypertrophic And Keloid Scar Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hypertrophic And Keloid Scar Market

• 9.1. China Hypertrophic And Keloid Scar Market Overview
• 9.2. China Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hypertrophic And Keloid Scar Market

• 10.1. India Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hypertrophic And Keloid Scar Market

• 11.1. Japan Hypertrophic And Keloid Scar Market Overview
• 11.2. Japan Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hypertrophic And Keloid Scar Market

• 12.1. Australia Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hypertrophic And Keloid Scar Market

• 13.1. Indonesia Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hypertrophic And Keloid Scar Market

• 14.1. South Korea Hypertrophic And Keloid Scar Market Overview
• 14.2. South Korea Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hypertrophic And Keloid Scar Market

• 15.1. Western Europe Hypertrophic And Keloid Scar Market Overview
• 15.2. Western Europe Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hypertrophic And Keloid Scar Market

• 16.1. UK Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hypertrophic And Keloid Scar Market

• 17.1. Germany Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hypertrophic And Keloid Scar Market

• 18.1. France Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hypertrophic And Keloid Scar Market

• 19.1. Italy Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hypertrophic And Keloid Scar Market

• 20.1. Spain Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hypertrophic And Keloid Scar Market

• 21.1. Eastern Europe Hypertrophic And Keloid Scar Market Overview
• 21.2. Eastern Europe Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hypertrophic And Keloid Scar Market

• 22.1. Russia Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hypertrophic And Keloid Scar Market

• 23.1. North America Hypertrophic And Keloid Scar Market Overview
• 23.2. North America Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hypertrophic And Keloid Scar Market

• 24.1. USA Hypertrophic And Keloid Scar Market Overview
• 24.2. USA Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hypertrophic And Keloid Scar Market

• 25.1. Canada Hypertrophic And Keloid Scar Market Overview
• 25.2. Canada Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hypertrophic And Keloid Scar Market

• 26.1. South America Hypertrophic And Keloid Scar Market Overview
• 26.2. South America Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hypertrophic And Keloid Scar Market

• 27.1. Brazil Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hypertrophic And Keloid Scar Market

• 28.1. Middle East Hypertrophic And Keloid Scar Market Overview
• 28.2. Middle East Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hypertrophic And Keloid Scar Market

• 29.1. Africa Hypertrophic And Keloid Scar Market Overview
• 29.2. Africa Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hypertrophic And Keloid Scar Market Competitive Landscape And Company Profiles

• 30.1. Hypertrophic And Keloid Scar Market Competitive Landscape
• 30.2. Hypertrophic And Keloid Scar Market Company Profiles
  • 30.2.1. Smith & Nephew plc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merz Pharmaceutical LLC
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Lumenis Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Enaltus LLC
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Sonoma Pharmaceuticals Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Hypertrophic And Keloid Scar Market Competitive Benchmarking

32. Global Hypertrophic And Keloid Scar Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Hypertrophic And Keloid Scar Market

34. Hypertrophic And Keloid Scar Market Future Outlook and Potential Analysis

• 34.1 Hypertrophic And Keloid Scar Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Hypertrophic And Keloid Scar Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Hypertrophic And Keloid Scar Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer